4,4,5,5-Tetramethyl-2-phenethyl-1,3,2-dioxaborolane, 95.0%, 25g

[(5-fluoro-1H-indol-2-yl)methyl]methylamine sulfate (2:1), 95.0%, 1g

2-(2-Aminoethyl)-3',6'-bis(diethylamino)spiro[isoindoline-1,9'-xanthen]-3-one, 97%, 1g

4-Bromo-3-chloro-2-methylbenzoic acid, 95+%, 1g

Methyl (6-(propylsulfinyl)-1H-benzo[d]imidazol-2-yl)carbamate, 97%, 100g

3-(Cyclopropylmethoxy)piperidine, 95%, 5g

1-(7,8-Diamino-1,2,4,5-tetrahydro-1,5-methano-3H-3-benzazepin-3-yl)-2,2,2-trifluoroethanone, 98%, 100g

5-Sulfamoylfuran-2-carboxylic acid, 97.0%, 1g

1-Pyridin-2-yl-ethanol, 98.0%, 25g

3-Hidroxibenzaldehído, mínimo 97%, para síntesis, 100 g, envase de plástico.

Dimethyl 4-iodo-1H-pyrazole-3,5-dicarboxylate, 95.0%, 1g

Fluoruro de tetrabutilamonio, 1 mol/l en THF, stab., 250 ml, envase de vidrio

1-(QUINOXALIN-6-YL)ETHAN-1-OL, 95.0%, 250mg